Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prashant Tembhare

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|July 28, 2023
Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with VenetoclaxTarang Gaur, Ramulu Poddutoori, Leena Khare, et al.
Blood Advances|February 26, 2021
Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocolAkhil Rajendra, Hasmukh Jain, V N Avinash Bonda, et al.
Annals of Hematology|July 21, 2023
Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) - experience from Tata Memorial Hospital, IndiaNirmalya Roy Moulik, Swaminathan Keerthivasagam, Swetha V Velagala, et al.
Cancer Medicine|July 16, 2025
Moving Beyond G-CSF Mobilization-Learning From a 15-Year Experience of Different Stem Cell Mobilization Regimens in Multiple MyelomaSumeet Mirgh, Bhausaheb Bagal, Sachin Punatar, et al.
Blood Cells, Molecules & Diseases|July 22, 2020
Investigating the clinical, hematological and cytogenetic profile of endoreduplicated hypodiploids in BCP-ALLDhanlaxmi Shetty, Pratibha Kadam Amare, Purvi Mohanty, et al.
Molecular Carcinogenesis|February 13, 2026
TGFβ-Mediated Overexpression of Podoplanin Serves as a Potential Diagnostic Biomarker in Acute Promyelocytic LeukemiaAkash Maity, Rohit Kumar, Madhavi Dutta, et al.
British Journal of Haematology|December 15, 2023
Treatment and follow-up of children with chronic myeloid leukaemia in chronic phase (CML-CP) in the tyrosine kinase inhibitor (TKI) era-Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohortNirmalya Roy Moulik, Swaminathan Keerthivasagam, Ankita Pandey, et al.
The Lancet Regional Health. Southeast Asia|June 9, 2025
Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from IndiaManash Pratim Gogoi, Parag Das, Nandana Das, et al.
Current Problems in Cancer|May 8, 2026
Advancements and perspectives of neoadjuvant immunotherapy in resectable non-small cell lung cancerAparna Sharma, Praful Pandey, Swasthik Upadhya, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|October 29, 2024
Real World Outcomes with Treatment Free Remission in Chronic Myeloid Leukemia-Experience from a Tertiary Care Cancer CentreRup Jyoti Sarma, Lakhan Kashyap, Anne Srikanth, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Journal of Experimental & Clinical Cancer Research : CR|July 28, 2023
Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with VenetoclaxTarang Gaur, Ramulu Poddutoori, Leena Khare, et al.
Blood Advances|February 26, 2021
Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocolAkhil Rajendra, Hasmukh Jain, V N Avinash Bonda, et al.
Annals of Hematology|July 21, 2023
Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) - experience from Tata Memorial Hospital, IndiaNirmalya Roy Moulik, Swaminathan Keerthivasagam, Swetha V Velagala, et al.
Cancer Medicine|July 16, 2025
Moving Beyond G-CSF Mobilization-Learning From a 15-Year Experience of Different Stem Cell Mobilization Regimens in Multiple MyelomaSumeet Mirgh, Bhausaheb Bagal, Sachin Punatar, et al.
Blood Cells, Molecules & Diseases|July 22, 2020
Investigating the clinical, hematological and cytogenetic profile of endoreduplicated hypodiploids in BCP-ALLDhanlaxmi Shetty, Pratibha Kadam Amare, Purvi Mohanty, et al.
Molecular Carcinogenesis|February 13, 2026
TGFβ-Mediated Overexpression of Podoplanin Serves as a Potential Diagnostic Biomarker in Acute Promyelocytic LeukemiaAkash Maity, Rohit Kumar, Madhavi Dutta, et al.
British Journal of Haematology|December 15, 2023
Treatment and follow-up of children with chronic myeloid leukaemia in chronic phase (CML-CP) in the tyrosine kinase inhibitor (TKI) era-Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohortNirmalya Roy Moulik, Swaminathan Keerthivasagam, Ankita Pandey, et al.
The Lancet Regional Health. Southeast Asia|June 9, 2025
Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from IndiaManash Pratim Gogoi, Parag Das, Nandana Das, et al.
Current Problems in Cancer|May 8, 2026
Advancements and perspectives of neoadjuvant immunotherapy in resectable non-small cell lung cancerAparna Sharma, Praful Pandey, Swasthik Upadhya, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|October 29, 2024
Real World Outcomes with Treatment Free Remission in Chronic Myeloid Leukemia-Experience from a Tertiary Care Cancer CentreRup Jyoti Sarma, Lakhan Kashyap, Anne Srikanth, et al.
Pageof 9